LOMOTIL Tablet (2019)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
Name of the medicinal product
LOMOTIL - (Diphenoxylate hydrochloride and atropine sulfate tablets USP, 2.5 mg/0.025 mg). Anti-Diarrheal Agent.
Indications and clinical use
LOMOTIL (diphenoxylate hydrochloride with atropine sulfate) is indicated as an adjunct in the management of diarrhea. Bacterially-induced diarrhea should be treated with appropriate antimicrobial therapy. ...
Contraindications
LOMOTIL (diphenoxylate hydrochloride with atropine sulfate) is contraindicated in patients with a known hypersensitivity to diphenoxylate hydrochloride or atropine sulfate, and in patients who are jaundiced. ...
Warnings and precautions
LOMOTIL (DIPHENOXYLATE HYDROCHLORIDE WITH ATROPINE SULFATE) IS NOT AN INNOCUOUS DRUG AND DOSAGE RECOMMENDATIONS SHOULD BE STRICTLY ADHERED TO, ESPECIALLY IN CHILDREN. LOMOTIL (DIPHENOXYLATE HYDROCHLORIDE ...
Adverse reactions
The most frequently reported adverse effect is nausea. Other symptoms which have been reported at therapeutic doses are: <u>General Disorders:</u> Malaise. <u>Nervous System:</u> Drowsiness, coma, lethargy, ...
Dosage and administration
Adults The usual initial dose of LOMOTIL (diphenoxylate hydrochloride with atropine sulfate) is 5 mg (2 tablets) 3 or 4 times daily (20 mg/24 hrs in divided doses is the maximum recommended dosage). An ...
Overdosage
<b>If you think you have taken too much LOMOTIL, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.</b> Diphenoxylate ...
Dosage forms, composition and packaging
<b>Tablets</b> - Each white, round tablet with SEARLE debossed on one side and 61 on the other side, contains 2.5 mg of diphenoxylate hydrochloride and 0.025 mg of atropine sulfate. <u>Non-medicinal ingredients: ...
Pharmaceutical information
Proper Name: Diphenoxylate hydrochloride Common Name: 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate Structural formula: Empirical Formula: C<sub>30</sub>H<sub>32</sub>N<sub>2</sub>O ...
Detailed pharmacology
The mode of action of diphenoxylate in the bowel is similar to that of morphine and related drugs. Gastrointestinal propulsion is inhibited through a direct action on the smooth muscle, resulting in a ...
Marketing authorization holder
Pfizer Canada ULC, 17,300 Trans-Canada Highway, Kirkland, Quebec H9J 2M5
Submission control number
222941
Date of revision
April 17, 2019
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
